Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MiNK Therapeutics, Inc. - Common Stock
(NQ:
INKT
)
12.25
-0.19 (-1.54%)
Delayed Quote
Updated: 11:30 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MiNK Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
January 08, 2026
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
November 20, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
MiNK Therapeutics (INKT) Earnings Call Transcript
↗
November 14, 2025
MiNK Therapeutics (INKT) Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation
November 14, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics's Earnings Outlook
↗
November 13, 2025
Via
Benzinga
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
November 07, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
November 05, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
October 30, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors
September 29, 2025
Strengthening Leadership to Accelerate iNKT Therapies into Immune-Mediated Disease, Pulmonary Disorders, and Global Health Security
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA
September 25, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development
September 18, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Extends Cash Runway
↗
August 14, 2025
Via
The Motley Fool
MiNK INKT Q2 2025 Earnings Call Transcript
↗
August 14, 2025
Via
The Motley Fool
Topics
Earnings
MiNK Therapeutics Inc (NASDAQ:INKT) Reports Wider Q2 2025 Loss, Advances Clinical Pipeline Amid Market Caution
↗
August 14, 2025
MiNK Therapeutics Q2 2025 earnings miss EPS estimates with a $1.06 loss per share, but cash runway extends to mid-2026. Clinical progress in cancer and GvHD offers future potential.
Via
Chartmill
Topics
Earnings
MiNK Therapeutics Cuts Q2 Cash Use 31%
↗
August 14, 2025
Via
The Motley Fool
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
August 14, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
July 31, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
On Thursday, there are stocks with unusual volume. Let's take a look.
↗
July 17, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 15, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
↗
July 15, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
July 15, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
July 15, 2025
Via
Benzinga
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
July 15, 2025
iNKT cells uniquely remodel the tumor microenvironment, overcome immune resistance, and enable scalable off-the-shelf cell therapy
From
MiNK Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 15, 2025
Via
Benzinga
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
↗
July 15, 2025
Via
Benzinga
These stocks are moving in today's session
↗
July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 14, 2025
Via
Benzinga
Unusual volume stocks in Monday's session
↗
July 14, 2025
Unusual volume stocks in Monday's session
Via
Chartmill
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
